Burning Sensations

'Listen to your patients for early identification of Peripheral Neuropathy' say leading Health Experts at P&G's #KNOWTHESIGNS Scientific Forum

Retrieved on: 
Monday, November 6, 2023
Global Medical Device Nomenclature, Patient, Ulcer, Education, PN, Prickle (protein), Neuropathic pain, Neurology, Assistant, Facial muscles, Physician, Prevalence, IDF, Burning Sensations, Health, International Diabetes Federation, DPN, Type 2 diabetes, WDD, Finger, Foot, Hypoesthesia, Senior, AMA, Prediabetes, Paresthesia, Quality of life, Bethesda Hospital, The, Extremities, Risk, P&G, Peripheral neuropathy, Lyceum, Trial of the century, B, Pharmacist, Ankle, Amputation, Diagnosis, Consultant, Infection, Dietary supplement, Pharmaceutical industry, Diabetes

The signature event saw deliberations on the latest clinical guidance on diagnoses and treatment of Peripheral Neuropathy (PN) in Diabetes and Pre-Diabetes.

Key Points: 
  • The signature event saw deliberations on the latest clinical guidance on diagnoses and treatment of Peripheral Neuropathy (PN) in Diabetes and Pre-Diabetes.
  • With Diabetes Mellitus Type 2 being the leading cause of PN, its increasing prevalence is closely linked to the rise in the number of diabetics.
  • B vitamin deficiency and polymedication are other high-risk factors along with diabetes, leading to peripheral nerve damage.
  • Patients should be educated about the importance of regular foot and DPN examinations, glycemic control, and adherence to prescribed medications.

P&G Health commemorates World Diabetes Day 2023 with innovative AI-based Experiential Campaign #KnowtheSigns

Retrieved on: 
Wednesday, November 1, 2023
Digital, Ageing, PN, Prickle (protein), Life, Prevalence, Burning Sensations, Diabetes, DPN, Artificial intelligence, Hypoesthesia, Senior, Quality of life, Somatosensory system, Paresthesia, B, Patient, Diagnosis, Nerve, Dietary supplement, B vitamins, Health, Peripheral neuropathy

SINGAPORE, Nov. 1, 2023 /PRNewswire/ -- Ahead of World Diabetes Day 2023, P&G Health, makers of Neurobion, continued awareness efforts with an innovative #KnowtheSigns campaign to help consumers and healthcare professionals understand the connection between Diabetes and Pre-Diabetes with Peripheral Neuropathy (PN) and Vitamin B Deficiency for timely detection, treatment, and improved quality of life.

Key Points: 
  • SINGAPORE, Nov. 1, 2023 /PRNewswire/ -- Ahead of World Diabetes Day 2023, P&G Health, makers of Neurobion, continued awareness efforts with an innovative #KnowtheSigns campaign to help consumers and healthcare professionals understand the connection between Diabetes and Pre-Diabetes with Peripheral Neuropathy (PN) and Vitamin B Deficiency for timely detection, treatment, and improved quality of life.
  • With Diabetes Mellitus being the leading cause1 of PN, the increasing prevalence of PN is closely linked to the rise in the number of diabetic patients.
  • Symptoms of PN include numbness, tingling, prickling, and burning sensations in the hands and feet.
  • B vitamin deficiency and aging are other high-risk factors along with diabetes, leading to peripheral nerve damage.

1 in 2 diabetics suffer from Peripheral Neuropathy[1] during their lifetime

Retrieved on: 
Tuesday, November 8, 2022
Paresthesia, Shoulder, Health professional, Pantene, Miracle Mineral Supplement, P&G, Ageing, Head & Shoulders, World Diabetes Day, DPN, International Diabetes Federation, Pain, Quality of life, Awareness, Risk, IDF, Neuropathic pain, Senior, Nerve Damage, Psyllium, Diabetes, Gillette, Education, Burning Sensations, Health, Digestive, Prickle (protein), Patient, Mortality, Vitamin, Omeprazole, Prevalence, Pregnancy, Vicks, PN, Physician, Febreze, Disease, Pharmacist, Mineral, Oral hygiene, Hypoesthesia, Phosphorus, Pharmaceutical industry, Dietary supplement, Tide, Crest, Pampers, Whispering, Peripheral neuropathy, B vitamins

Launched on World Diabetes Day across 18 countries, the campaign raises awareness on Peripheral Neuropathy in diabetes, and the importance of early identification and timely treatment.

Key Points: 
  • Launched on World Diabetes Day across 18 countries, the campaign raises awareness on Peripheral Neuropathy in diabetes, and the importance of early identification and timely treatment.
  • With Diabetes Mellitus being the leading cause[2] of Peripheral Neuropathy (PN), the increasing prevalence of PN is closely linked to the rise in the number of diabetic patients.
  • Symptoms of peripheral neuropathy include numbness, tingling, prickling, and burning sensations in the hands and feet.
  • Besides diabetes mellitus, B vitamins deficiencies and aging are other high-risk factors leading to peripheral nerve damage.

Southeast Asia & China Lip Cold Sore Treatment Market Report 2021: Increasing HSV-1 Infection Incidence - The Strongest Market Growth Driver - ResearchAndMarkets.com

Retrieved on: 
Wednesday, August 25, 2021
Health, Pharmaceutical, CAGR, Sore throat, Pain, Growth, Immunosuppression, Myalgia, Knowledge, Pharmacy, Pachydactylus labialis, Blister, Disease, Prevalence, Paresthesia, Lymph, Fatigue, SEA, Burning Sensations, Awareness, Infection, Risk, Lip, Fever, COVID-19, Headache, Sores, Cosmetics

The "Lip Cold Sore Treatment Market in China, South Korea, Taiwan, Hong Kong, and Southeast Asia -Revenue Estimation and Forecast by 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Lip Cold Sore Treatment Market in China, South Korea, Taiwan, Hong Kong, and Southeast Asia -Revenue Estimation and Forecast by 2030" report has been added to ResearchAndMarkets.com's offering.
  • In China and Southeast Asia (SEA), the prevalence of herpes simplex virus type-1 (HSV-1) infection is increasing.
  • As a result, the China and SEA lip cold sore treatment market was negatively affected due to the curtailed manufacturing activities and people staying home.
  • The pharmacies category dominated the China and SEA lip cold sore treatment market in the past, under segmentation by distribution channel.